Lantern Pharma Inc. Prepaid Expense and Other Assets, Current
Lantern Pharma Inc. (LTRN) had Prepaid Expense and Other Assets, Current of $1.10 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense and Other Assets, Current $1.10M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $734.41K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $683.95K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $1.10M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $1.10M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $734.41K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $683.95K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $1.10M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.30M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $1.10M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.23M 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.87M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.03M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.11M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.04M 10-K · filed 2025-03-27 |
| 2023-09-30 | $2.50M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $2.55M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $3.09M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.99M 10-K · filed 2024-03-18 |
| 2022-09-30 | $3.65M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $3.51M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $2.45M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $1.99M 10-K · filed 2023-03-20 |
| 2021-09-30 | $2.50M 10-Q · filed 2021-11-01 |
| 2021-06-30 | $2.54M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $1.11M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $1.01M 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.67M 10-Q · filed 2020-10-29 |
| 2019-12-31 | $788.00 10-K · filed 2021-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |